|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:approvalYear
|
1975
|
|
gptkbp:ATCCode
|
N03AE01
|
|
gptkbp:CASNumber
|
1622-61-3
|
|
gptkbp:chemicalFormula
|
C15H10ClN3O3
|
|
gptkbp:contraindication
|
acute narrow-angle glaucoma
severe liver disease
|
|
gptkbp:controlledSubstanceSchedule
|
Schedule IV (US)
|
|
gptkbp:drugClass
|
benzodiazepine
|
|
gptkbp:eliminatedIn
|
urine
|
|
gptkbp:genericName
|
gptkb:clonazepam
|
|
gptkbp:halfLife
|
18-50 hours
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Klonopin
|
|
gptkbp:interactsWith
|
gptkb:beer
opioids
other CNS depressants
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Roche
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
D (US)
|
|
gptkbp:prescriptionForm
|
gptkb:tablet
orally disintegrating tablet
|
|
gptkbp:riskFactor
|
dependence
abuse potential
withdrawal symptoms
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
dizziness
fatigue
drowsiness
coordination problems
|
|
gptkbp:synonym
|
gptkb:Rivotril
gptkb:clonazepam
|
|
gptkbp:usedFor
|
gptkb:panic_disorder
seizure disorders
|
|
gptkbp:bfsParent
|
gptkb:Clonazepam
gptkb:clonazepam
|
|
gptkbp:bfsLayer
|
7
|